FDA Warning Letter — Hangzhou Guoguang Touring Commodity Co.,Ltd.
The FDA took a Warning Letter action against Hangzhou Guoguang Touring Commodity Co.,Ltd. on Dec 14, 2018 (Hangzhou, China). The action was issued by CDER and concerns drugs products. This facility has 1 recent FDA inspection on record.
Action Details
- Facility
- Hangzhou Guoguang Touring Commodity Co.,Ltd.
- Date
- Dec 14, 2018
- Fiscal Year
- 2019
- Product Type
- Drugs
- Center
- CDER
- Location
- Hangzhou (China)